Teaching - Course details

Title Tuesday's Growth Control Seminars HS 2009 (#15602-01)
Location: FMI, Maulbeerstrasse 66, 4058 Basel Room 5.30 (unless otherwise indicated) Time: 12.15 h (with sandwiches)
Coordinator: Coordinator: Brian A. Hemmings
Aug 24, 2009 Derek Brazil, UCD Conway Institute, School of Biomolecular and Biomedical Science, University College Dublin, Ireland
Insulin signaling in development and disease
Sep 01, 2009 Shigenori Iwai, Graduate School of Engineering Science, Osaka University, Japan
Damaged DNA: chemical synthesis and applications to molecular biology
Sep 21, 2009 Peter Shepherd, University of Auckland, New Zealand
Understanding the role fo different isoforms of PI3-kinase in cellular function
Oct 20, 2009 Daniel Besser, Max Delbrueck Center (MDC) Berlin, Germany
Signalling mechanisms in pluripotency and reprogramming
Oct 27, 2009 Monilola Olayioye, Institute of Cell Biology and Immunology, University of Stuttgart, Germany
Deleted in liver cancer 1: a tumoor suppressor protein in control of Rho signaling and cell migration
Nov 05, 2009 George Thomas, Genome Research Institute, University of Cincinnati, Ohio, USA
Ribosome biogenesis, cell cycle checkpoints and cancer progression
Nov 10, 2009 Laurent Decosterd, Department of Medicine, University of Lausanne, Lausanne
Therapeutic drug monitoring (TDM) of new targete anti-cancer agents
Nov 17, 2009 Patrick Meraldi, Institute of Biochemistry, ETH Zurich
Finding the middle ground: how kinetochores control chromosomes movement
Nov 24, 2009 Eric O'Neill, Gray Institute for Radiation Oncology & Biology, University of Oxford, UK
Tumor suppressor signalling and the response to DNA damage
Dec 01, 2009 Lukas Sommer, Institute of Anatomy, University of Zurich
Stage- and area-specific growth control in neural stem cells
Dec 08, 2009 Joseph Jiricny, The Institute of Molecular Cancer Research, University Zurich
The human mismatch repair interactome
Dec 15, 2009 Thomas Sturgill, University of Virginia Health Sciences Center, Charlottesville, VA, USA
Activating mutations in TOR in similar structural elements as oncogenic mutaitons in PI3KC-alpha
About this site2018 © FMI Basel Switzerland